Julian Baker’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,559,231
Closed -$13.7M 117
2019
Q3
$13.7M Hold
1,559,231
0.09% 47
2019
Q2
$14.4M Buy
1,559,231
+1,053,991
+209% +$7.94M 0.1% 44
2019
Q1
$3.25M Buy
505,240
+350,565
+227% +$2.28M 0.02% 68
2018
Q4
$1.46M Hold
154,675
0.01% 80
2018
Q3
$3.11M Hold
154,675
0.02% 83
2018
Q2
$4.51M Hold
154,675
0.03% 78
2018
Q1
$4.61M Hold
154,675
0.04% 78
2017
Q4
$4.98M Hold
154,675
0.04% 78
2017
Q3
$5.38M Sell
154,675
-350,057
-69% -$11.3M 0.04% 76
2017
Q2
$15M Buy
504,732
+125,598
+33% +$3.6M 0.13% 39
2017
Q1
$11.3M Buy
379,134
+365,388
+2,658% +$9.33M 0.09% 48
2016
Q4
$241K Hold
13,746
﹤0.01% 131
2016
Q3
$327K Hold
13,746
﹤0.01% 131
2016
Q2
$220K Hold
13,746
﹤0.01% 133
2016
Q1
$287K Hold
13,746
﹤0.01% 129
2015
Q4
$371K Sell
13,746
-398,262
-97% -$10.9M ﹤0.01% 130
2015
Q3
$11.4M Hold
412,008
0.11% 59
2015
Q2
$10.1M Hold
412,008
0.09% 62
2015
Q1
$7.54M Sell
412,008
-9,623
-2% -$195K 0.06% 66
2014
Q4
$7.78M Hold
421,631
0.08% 56
2014
Q3
$4.05M Buy
421,631
+200,000
+90% +$1.99M 0.05% 70
2014
Q2
$2.04M Hold
221,631
0.02% 89
2014
Q1
$2.39M Buy
+221,631
New +$2.17M 0.03% 85

Other funds holding LJPC

Julian Baker's LJPC Position: Q4 2019 in Review

Julian Baker sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2019, closing a stake of 1,559,231 shares — an estimated $13.7M sold.

Julian Baker first reported a position in LJPC in Q1 2014 and held it in 23 quarters. The position peaked at $15M in Q2 2017. 77 funds tracked by Wall St. Rank hold LJPC as of Q4 2019.

  • Julian Baker reported no remaining La Jolla Pharmaceutical Company position as of Q4 2019 after selling out during the quarter.
  • Julian Baker sold 1,559,231 La Jolla Pharmaceutical Company shares in Q4 2019, an estimated $13.7M.
  • Julian Baker first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 23 quarters.
  • Julian Baker's La Jolla Pharmaceutical Company position peaked at $15M in Q2 2017.
  • 77 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2019.

Based on Baker Bros. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.